DD87029A - - Google Patents

Info

Publication number
DD87029A
DD87029A DD87029DA DD87029A DD 87029 A DD87029 A DD 87029A DD 87029D A DD87029D A DD 87029DA DD 87029 A DD87029 A DD 87029A
Authority
DD
German Democratic Republic
Application number
Publication of DD87029A publication Critical patent/DD87029A/xx

Links

DD87029D DD87029A (de)

Publications (1)

Publication Number Publication Date
DD87029A true DD87029A (de)

Family

ID=271611

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87029D DD87029A (de)

Country Status (1)

Country Link
DD (1) DD87029A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226830A3 (de) * 2001-01-25 2003-07-09 Pfizer Products Inc. Kombinationstherapie einschliessend einen Typ 1 Natrium-Wasserstoff-Austauscher- oder NHE-1- Hemmer zur Behandlung von Ischemie

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226830A3 (de) * 2001-01-25 2003-07-09 Pfizer Products Inc. Kombinationstherapie einschliessend einen Typ 1 Natrium-Wasserstoff-Austauscher- oder NHE-1- Hemmer zur Behandlung von Ischemie

Similar Documents

Publication Publication Date Title
US6114335A (en) Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines
RU98115533A (ru) Новые производные бензоилгуанидина, способ их получения и их применение при получении лекарственных средств
AR017513A1 (es) Preparado farmaceutico combinado que contiene un inhibidor del intercambiador entre sodio e hidrogeno y envase comercial destinado al tratamientode enfermedades cardiocirculatorias
HK1048265A1 (zh) 联合疗法
DD87029A (de)